Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
14 janv. 2025 06h15 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...